SLC26A9 and chronic pancreatitis: Further, pharmacological activation of SLC26A9-mediated chloride/fluid secretion may also be beneficial in other muco-obstructive lung diseases and in chronic pancreatitis (Mall, 2016; Balázs et al., 2018).